HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shuang-Shuang Dong Selected Research

Heterogeneous-Nuclear Ribonucleoprotein Group M

1/2022Targeting HNRNPM Inhibits Cancer Stemness and Enhances Antitumor Immunity in Wnt-activated Hepatocellular Carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shuang-Shuang Dong Research Topics

Disease

5Neoplasms (Cancer)
01/2022 - 09/2019
2Synovial Sarcoma (Synovioma)
02/2022 - 01/2021
2Neoplasm Metastasis (Metastasis)
01/2021 - 01/2021
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Carcinoma (Carcinomatosis)
01/2021
1Liver Neoplasms (Liver Cancer)
01/2021
1Sarcoma (Soft Tissue Sarcoma)
01/2021

Drug/Important Bio-Agent (IBA)

1SYT-SSX fusion proteinIBA
02/2022
1RNA Splicing FactorsIBA
01/2022
1Heterogeneous-Nuclear Ribonucleoprotein Group MIBA
01/2022
1MicroRNAs (MicroRNA)IBA
01/2021
1human ERBB2 proteinIBA
01/2021
1Circular RNAIBA
01/2021
1Keratins (Keratin)IBA
01/2021
1Progesterone Receptors (Progesterone Receptor)IBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1VimentinIBA
01/2021
1Cadherins (E-Cadherin)IBA
01/2021
1Estrogen ReceptorsIBA
01/2021
16-methyladenineIBA
01/2020
1N-methyladenosineIBA
01/2020
1RNA (Ribonucleic Acid)IBA
01/2020
1Genetic Markers (Genetic Marker)IBA
12/2019
1Adenosine Triphosphatases (ATPase)IBA
09/2019
1ATPases Associated with Diverse Cellular ActivitiesIBA
09/2019

Therapy/Procedure

1Immunotherapy
01/2022
1Drug Therapy (Chemotherapy)
01/2021
1Therapeutics
01/2021
1Radiotherapy
01/2021